The FDA approved Moderna's mFlusiva in August, and it's now available to adults 50 and older.

The FDA’s approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu ...

The FDA-approved Moderna mRNA flu vaccine offers better protection against influenza A but comes with mild side effects, and doctors advise getting vaccinated by late October for optimal coverage.

For some older adults, the flu vaccine could look a little different this year. In August, the US Food and Drug Administration approved the nation’s first mRNA-based flu vaccine for use in people 50 ...

mRNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the blueprint for functional proteins into the body so that induces therapeutic ...

People looking to get their annual flu shot this fall may find a new option alongside the usual vaccines: an mRNA flu shot. Not everyone is eligible, however.

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process ...